| 8.50 Data as of May 23 |  +0.27 / +3.28%Today’s Change | 3.72 Today|||52-Week Range 9.65 | +35.35% Year-to-Date |
| Previous close | 8.23 |
| Today’s open | 8.09 |
| Day’s range | 8.04 - 8.57 |
| Volume | 339,674 |
| Average volume (3 months) | 306,918 |
| Market cap | $258.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +24.44% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +99.15% |
| P/E ratio | 17.7 |
| Price/Sales | 3.12 |
| Price/Book | 3.05 |
| Today’s change | Today’s % change | |
|---|---|---|
| SCLNSciClone Pharmaceuti... | +0.20 | +4.19% |
| RGLSRegulus Therapeutics... | +0.20 | +2.80% |
| XNPTXenoport Inc | 0.00 | 0.00% |
| CNDOCoronado Biosciences... | +0.24 | +2.56% |
| Next reporting date | November 7, 2013 |
| EPS forecast (this quarter) | $0.10 |
| Annual revenue (last year) | $62.3M |
| Annual profit (last year) | $14.2M |
| Net profit margin | 22.73% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Walter C. Herlihy, PhD |
Senior Vice President- Global Operations Daniel P. Witt, PhD |
Corporate headquarters Waltham, Massachusetts |
.
